MigVax Ltd
MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in human.
Last updated on
About MigVax Ltd
Estimated Revenue
$10M-$50MEmployees
51-250Category
Location
City
Qiryat ShemonaState
Northern DistrictCountry
IsraelMigVax Ltd
Find your buyer within MigVax Ltd